Literature DB >> 21499486

The sensitivities to first-line antibiotic therapy of the common urinary tract bacterial infections detected in urine samples at a hospital in metropolitan Kampala (Uganda).

D Kyabaggu1, F Ejobi, D Olila.   

Abstract

BACKGROUND: Urinary tract infections (UTIs) are among the most common human infections. Many urinary tract bacteria are capable of expressing drug resistance. Resistant bacteria may be present from the commencement of the infection or may develop during treatment. This study focused on the problem of antibiotic resistance to the first-line drugs that were used to treat patients presenting with urinary tract infections at Rubaga hospital in Kampala, Uganda.
OBJECTIVES: The objective of this study was to isolate and identify the major bacterial pathogens of symptomatic and asymptomatic UTIs among patients at Rubaga hospital. Furthermore, the study sought to determine the antimicrobial susceptibility patterns of the major bacterial isolates to the first-line drugs used to treat UTIs at Rubaga hospital.
METHODS: Urine samples were aseptically collected and examined microscopically and were microbiologically cultured on blood agar, nutrient agar and on MacConkey agar. The isolates obtained were then identified using standard tests and tested for antimicrobial sensitivity by the Kirby-Bauer technique.
RESULTS: The isolated pathogens included Escherichia coli (10.9%), Staphylococcus (31.9%), Streptococcus (9.2%), Klebsiella species (21.0%) and Proteus species (10.1%). 20 (16.8%) of the isolates were lactose fermenting gram-negative rods that were also indole-negative. These isolates were termed 'unclassified coliforms' in this study but were probably Enterobacter species. On antimicrobial susceptibility testing, all the gram-negative isolates were significantly resistant to amoxycillin, cotrimoxazole, erythromycin, and to nalidixic acid; but were susceptible to nitrofurantoin. Among the gram-negative isolates, only Klebsiella species were significantly resistant (p<0.05) to ciprofloxacin. The gram-positive cocci were susceptible to amoxycillin, ciprofloxacin, and to erythromycin but resistant to cotrimoxazole and nalidixic acid. Unlike the Staphylococcus species that were significantly resistant to nitrofurantoin, Streptococcus species were moderately susceptible to the drug.
CONCLUSION: The common urinary tract bacteria detected in Rubaga hospital in Uganda were most sensitive to Ciprofloxacin and Nitrofurantoin.

Entities:  

Keywords:  UrinaryTract Infections (UTI); ciprofloxacin; drug sensitivity; nitrofurantoin; resistance

Mesh:

Substances:

Year:  2007        PMID: 21499486      PMCID: PMC3074367     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  4 in total

1.  URINARY CELL COUNTS AND THEIR VALUE.

Authors:  W BRUMFITT
Journal:  J Clin Pathol       Date:  1965-07       Impact factor: 3.411

2.  Bacteriuria localization and response to single-dose therapy in women.

Authors:  A R Ronald; P Boutros; H Mourtada
Journal:  JAMA       Date:  1976-04-26       Impact factor: 56.272

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 4.  The natural history of urinary infection in adults.

Authors:  A R Ronald; A L Pattullo
Journal:  Med Clin North Am       Date:  1991-03       Impact factor: 5.456

  4 in total
  2 in total

1.  Factors associated with community-acquired urinary tract infections among adults attending assessment centre, Mulago Hospital Uganda.

Authors:  Deus Kabugo; Samuel Kizito; Dave Dhara Ashok; Kiwanuka Alexander Graham; Ronald Nabimba; Sandra Namunana; M Richard Kabaka; Beatrice Achan; Florence C Najjuka
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  Antibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study.

Authors:  Charles O Odongo; Denis A Anywar; Kenneth Luryamamoi; Pancras Odongo
Journal:  BMC Infect Dis       Date:  2013-04-29       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.